It’s not right to assume that all models and makes of Electronic Cigarettes are prone to this type of thing happening. We always tell our customers to replace their batteries often and do not use them outside of their intended use. We take great pride in educating the customers about the product, so they know how it works and how to take care of it.
The electronic cigarette has been under fire for the last few years by the FDA and other anti-smoking organizations, that this article seems to have gained extra momentum. I firmly believe the Electronic Cigarette is a safer and smarter choice when compared to smoking tobacco cigarettes, let’s not forget the fact that approximately 138 people will die today in the USA alone from smoking related illnesses. That is a staggering number and could easily be avoided if smokers everywhere could make the switch to the Electronic Cigarette.
Allow us to point you toward documentation of the decrease in smoking and smoking-related diseases in countries that permit and promote smokeless tobacco products such as snus (finely milled tobacco contained in small sachets that are inserted between the lip and the gum), which suggests that this type of product may actually help smokers quit. Would-be quitters have also reported significant success with the electronic cigarette, which allows them to inhale a dose of nicotine without the carcinogenic products of tobacco combustion. Unfortunately, ACSH advisor Dr. Brad Rodu's 2011 study in the Harm Reduction Journal reported that smokers remain largely misinformed about the relative safety of these products compared to cigarettes.
Tobacco harm reduction will only succeed when smokers and their physicians are educated about snus and other cigarette alternatives. Although awareness among Norwegian doctors is not optimal, it should be sufficient to reduce cigarette consumption in that country.
And of course, true to form, Dr. Ross points out that while the authors of the study found what many would consider a “high quit rate” — between 22 and 25 percent — this rate is still unacceptably low. “When rates like this are actually considered high, it becomes clear that public health officials need to consider other options for cutting down on smoking in this country, particularly the potential of tobacco harm reduction,” he says.
The FDA Tobacco Products Scientific Advisory Committee (TPSAC) held a public hearing January 18-20 on dissolvable smokeless tobacco products. The information gleaned there will help inform a congressionally mandated report on the subject, due March 23.
The proceedings (agenda here) underscored the dearth of information on dissolvable tobacco use. Committee members repeatedly observed that there is no reliable data on who uses these products and in what context. Are dissolvables temporary or permanent substitutes for cigarettes? Do they promote tobacco initiation among teenagers?
Where the editorial argues that certain dissolvable smokeless tobacco products have “a youthful appeal,” Dr. Ross counters that these products are certainly not marketed to children. Even if these products are flavored, the taste of tobacco would render them unappealing to children, he points out. “This is in contrast to the flavored FDA-approved nicotine lozenges, which actually have more nicotine than dissolvable tobacco products do. And most importantly,” he observes, “these arguments ignore the important potential of certain modern smokeless tobacco products, such as snus and dissolvables, to help smokers quit.”
“Wouldn’t it be nice,” ACSH’s Dr. Elizabeth Whelan asks, “if these patients had a spectrum of smokeless products, which are both effective and at least 90 percent less harmful than cigarettes, to choose from?” ACSH's Dr. Gilbert Ross agrees. “It’s absurd that we’re recognizing the benefits of harm reduction for IV drug addicts, but we won’t acknowledge how much it would help people who can’t quit smoking even after a cancer diagnosis.”